Tripos Shares Lose Ground Gained on Pfizer Extension | GenomeWeb

NEW YORK, Nov. 18 (GenomeWeb News) - Shares in Tripos lost almost all the ground they gained since Monday, when the company said it had extended a multimillion-dollar software license agreement with Pfizer.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.